Publicacions científiques

Chitnis T, Singhal T, Zurawski J, Saraceno TJ, Gopalakrishnan N, Cain L, LaBarre B, King D, Bergmark RW, Maxfield AZ, Cicero S, Pan H, Dubey S, Vaquerano S, Hansel C, Healy B, Saxena S, Lokhande H, Baharnoori M, Madill E, Sheth M, Rodin R, Ye J, Clementi N, Clementi WA, Weiner HL.

Any publicació:

2026

Número de revista:

Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2

https://www.neurology.org/doi/full/10.1212/NXI.0000000000200543

National Trends in Medicare Charges and Reimbursement for Inpatient Neurologic Care, 2013-2023.

Autor/s:

Wong KH, Castillo M, King J, Bouldin E, Rose JW, Majersik JJ, Reddy V, de Havenon A, Clardy SL.

Clinical/Scientific Notes

Any publicació:

2026

Número de revista:

Neurology vol. 107 n. 6

https://www.neurology.org/doi/full/10.1212/WNL.0000000000218460

Article

Natural History of Adult-Onset Myotonic Dystrophy Type 1: Longitudinal Changes in Radiologic, Clinical, and Patient-Reported Outcomes.

Autor/s:

Iterbeke L, Huysmans L, Bamps K, Peeters R, Goosens V, Maes F, Dupont P, Claeys KG.

Any publicació:

2026

Número de revista:

Neurology vol. 107 n. 4

https://www.neurology.org/doi/full/10.1212/WNL.0000000000218349

Una iniciativa de:

Cercador

Musculoskeletal Ultrasound Curriculum Development in Physical Medicine and Rehabilitation Residency: Process, Outcomes, and Insights.

Music listening for fatigue after acquired brain injury: A scoping review project with patient, carer and public involvement (PCPI) data.

Mycelia

Myelin Oligodendrocyte Glycoprotein Antibodies in Breast Milk in a Lactating Woman With Severe Enterovirus-Associated MOGAD.

NABIS Abstracts

Nanoformulated fingolimod attenuates NLRP3 inflammasome activation and promotes functional recovery in a rat model of spinal cord injury.

Nanoformulated fingolimod for spinal cord injury: promising anti‑neuroinflammatory effects but unsubstantiated bioavailability claims.

Nasal foralumab treatment of PIRA induces regulatory immunity, dampens microglial activation and stabilizes clinical progression in non-active secondary progressive MS.

National Trends in Medicare Charges and Reimbursement for Inpatient Neurologic Care, 2013-2023.

Natural History of Adult-Onset Myotonic Dystrophy Type 1: Longitudinal Changes in Radiologic, Clinical, and Patient-Reported Outcomes.

Trobes a faltar informació? Fes-nos arribar els teus suggeriments!